- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04454957
Mastering Diabetes Study
Effectiveness of a Virtual Therapeutic Lifestyle Change Program for Diabetes and Prediabetes
This is a program evaluation that will evaluate the effectiveness of Mastering Diabetes, a therapeutic lifestyle change (TLC) program to control prediabetes and type 2 diabetes.
Lifestyle change, focused on dietary change, physical activity, stress management and control of unhealthy substances has been demonstrated effective in preventing the progression of prediabetes, as well as reversal of diabetes and type 2 diabetes mellitus (T2DM).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This will be a nonrandomized controlled study. Participants will self select to be a part of this intervention. The control data will be aggregated matched data from participants in the corporate wellness program at Memorial Health System, who choose not to participate in the intervention.
Study participants will have met the inclusion criteria. Potential participants will be provided with a short summary of this program as a potential activity for their participation, with a link leading to a landing page, which will explain the study in more detail, and will include a link to the consent.
If the potential participant is interested, they can click the link to move to the on line consent. If they agree to the consent, they will be taken to an on line HIPAA release form, which will also need an electronic agreement to be enrolled into the study signified by typing in the participant's name and date of birth.
Once this is completed, an email with an enrollment code and link to Mastering Diabetes will be sent the participant.
Mastering Diabetes Program Description:
The Mastering Diabetes Program is based on the Mastering Diabetes Method, which is based on almost 100 years of evidence based research demonstrating the effectiveness of a low-fat, plant-based, whole-food diet to reverse insulin resistance. Members are provided with a step-by-step online course that educates them how to transition to a low-fat, plant-based, whole-food lifestyle and reduce the overwhelm associated with ineffective pharmaceutical medication and ineffective dietary advice.
The online course provides members with detailed information about the root cause of insulin resistance, the effect of a high-fat diet on increasing insulin resistance, how to achieve excellent blood glucose values in the short-term and in the long-term, what laboratory tests to get to measure progress, an overview of oral diabetes medication and insulin, how to track hour-by-hour decisions for excellent blood glucose control, how to lose weight permanently using a low-fat, plant-based, whole-food diet, how to buy food, where to buy food, how to prepare food easily, the benefits of intermittent fasting for improved insulin sensitivity, how to perform an intermittent fast for excellent results, how to adopt an exercise regimen, how to control your blood glucose before, during, and after exercise, how to change your breakfast, lunch, dinner, and also provides members with a collection of delicious and simple recipes.
The program also provides members with direct access to expert coaches via an online community containing thousands of others living with all forms of diabetes, including type 1 diabetes, type 1.5 diabetes, prediabetes, type 2 diabetes, and gestational diabetes. In addition, members get access to live biweekly Q&A videoconferences in which they can interact with coaches and personalize their experience. The cost of full coaching program is $399 for the first 3 months, then $99 per month thereafter.
Participants, having enrolled in the wellness program, will already, as a part of that study, have agreed to have data collected at baseline and yearly thereafter, including BMI, blood pressure, resting pulse, lipid panel, hemoglobin A1c, health risk assessment survey, absenteeism and health claims data at baseline and yearly thereafter. If not collected within 60 days, a new set of data will be collected to serve as baseline for this study. This is not specific for this study, but is the case for any new program activity that a participant in the corporate wellness study begins.
Specifically for this study the health risk assessment data collection (including lab analysis) will also be repeated at 12 weeks. The lab work is accomplished at any MHS lab facility, according to current medical system standards.
Participant health claims data will also be evaluated, beginning with the prior year's data, if available from MHS Human Resources, being utilized as a baseline, and followed for the subsequent years of the study.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Athens, Ohio, United States, 45701
- Ohio University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18-75 years at enrollment
- Has a diagnosis of diabetes or prediabetes or a HbA1c of 5.7 or higher.
- Are able to participate in physical activity.
- Are willing to use a smartphone or computer to access the online education modules and online community, and have reliable daily Internet access with a device with a webcam
- Have an email account and an Internet connection at home
- Are able to purchase and transport fresh produce from a local grocery store to their house on a weekly basis
- Are able to prepare food in their house or get help preparing food in their house following recipes and meal examples provided in the online course
- Are open-minded about eating a plant-based diet, performing periodic intermittent fasting (16-24 hours, once a week),
- Are willing to increase movement of their body 5-6 days per week
- Are willing to participate in an online community for support and coaching
- Are willing to participate in biweekly videoconferencing for support and coaching
- Are willing to be courteous and respectful to others in the online community
Exclusion Criteria:
- Has been told by a medical provider to not participate in physical activity.
- Has a medical condition that prevents walking at least a mile a day.
- Deemed unsuitable to exercise by Dr. Drozek or other members of the wellness team.
- Has a diagnosis of dementia.
- Is pregnant or planning to become pregnant during the program
- Does not speak or understand English
- Advanced renal disease (stage 4 or 5) with or without hemodialysis
- Congestive heart failure
- Has inflammatory bowel disease (Crohns disease, ulcerative colitis)
- Is fed by a feeding tube
- Is taking Coumadin or warfarin
- Inability to use email, a smartphone, or the Internet
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mastering Diabetes
Adults (hospital employees, their spouses, and community members) who have been identified as having diabetes or prediabetes based on a health risk assessment, who have chosen to participate in Mastering Diabetes.
They may or may not be receiving additional usual care.
|
Virtual (on-line) lifestyle change program, focused on a plant-based, whole food diet and physical activity.
|
|
No Intervention: Usual care
Employees and spouses of the hospital system who are participating in the employee wellness program, who have been identified as having diabetes or prediabetes based on a health risk assessment, who have chosen not to participate in Mastering Diabetes.
They may or may not be receiving additional usual care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
HbA1c
Time Frame: up to 20 years
|
glycosylated hemoglobin measured from venous blood
|
up to 20 years
|
|
BMI
Time Frame: up to 20 years
|
Body mass index calculated from height and weight
|
up to 20 years
|
|
Healthcare expenditures
Time Frame: up to 20 years
|
Monetary amount spent for healthcare
|
up to 20 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total cholesterol
Time Frame: baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
|
Measured from a lipid panel done on venous blood
|
baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
|
|
Low density lipoprotein cholesterol
Time Frame: baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
|
Calculated from a lipid panel done on venous blood
|
baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
|
|
High density lipoprotein cholesterol
Time Frame: baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
|
Measured from a lipid panel done on venous blood
|
baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
|
|
Triglyceride
Time Frame: baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
|
Measured from a lipid panel done on venous blood
|
baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
|
|
Exercise level
Time Frame: baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
|
Amount of time spent per week in moderate to vigorous physical activity
|
baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
|
|
Dietary Recall
Time Frame: baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
|
Daily or weekly average of foods consumed during the last 7 days
|
baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
|
|
Patient Health Questionnaire
Time Frame: baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
|
mood screening questions; two for anxiety
|
baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
|
|
Patient Health Questionnaire
Time Frame: baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
|
mood screening questions; two for depression.
|
baseline, 12 weeks, 1 yearly, then yearly for up to 20 years
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20-X-96
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
ENBIOSIS BIOTECHNOLOGIESAydin Adnan Menderes University; Izmir University of Economics; Buca Seyfi Demirsoy... and other collaboratorsRecruitingType 2 Diabetes | Diabetes Mellitus Type 2Turkey (Türkiye)
-
Instituto Nacional de Ciencias Medicas y Nutricion...Active, not recruiting
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes Mellitus | Type 2 Diabetes | Type2diabetes
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type2Diabetes
-
University of SalamancaUniversity of Salamanca; Instituto Piaget; Escola Superior de Tecnologia da Saúde...Enrolling by invitationType 2 Diabetes Mellitus | Aging | Hyperglycemia Due to Type 2 Diabetes MellitusPortugal
-
Kaiser PermanenteThe Permanente Medical GroupEnrolling by invitationType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2D)United States
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Ohio State UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruitingT2DM (Type 2 Diabetes Mellitus)United States
-
San Diego State UniversityUniversity of California, Berkeley; National Institute on Minority Health and...RecruitingDiabetes Mellitus | Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus Type 2 (T2DM)United States
Clinical Trials on Mastering Diabetes
-
Boston University Charles River CampusRecruitingMental Disorders | Employment | Employment, Supported | MetacognitionUnited States
-
Peking University Sixth HospitalCompletedAttention Deficit DisorderChina
-
Women and Infants Hospital of Rhode IslandCompletedAdolescent Behavior | Language Development | Development, Child | Language Delay
-
Chinese University of Hong KongNot yet recruitingPhysical Activity | Knowledge, Attitudes, Practice | Motivation | Peer Group | Competence | Confidence, Self
-
Société des Produits Nestlé (SPN)Nestle Health ScienceCompletedDiabetes MellitusChina
-
Medstar Health Research InstituteNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)CompletedAttention Deficit Disorder With HyperactivityUnited States
-
Montefiore Medical CenterTerminatedSexual Dysfunction | Amputation; Traumatic, Limb | Diabetic Ulcers on Both Feet | Diabetic Foot Ulcer IschemicUnited States
-
Vanderbilt UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedType 2 DiabetesUnited States